Sagimet Biosciences, Inc. Class A (SGMT)
NASDAQ:SGMT
US Market
Holding SGMT?
Track your performance easily

Sagimet Biosciences, Inc. Class A (SGMT) Ownership - Who Owns Sagimet Biosciences, Inc. Class A?

440 Followers

Sagimet Biosciences, Inc. Class A (SGMT) Ownership Overview

58.93%6.62%0.50%3.53%30.42%
58.93% Insiders
0.50% Other Institutional Investors
3.53% ETFs
30.42% Public Companies and Individual Investors
The ownership structure of Sagimet Biosciences, Inc. Class A (SGMT) stock is a mix of institutional, retail, and individual investors. Approximately 10.65% of the company’s stock is owned by Institutional Investors, 58.93% is owned by Insiders, and 30.42% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 23, 2024
George Kemble
Ec,director
xxxxxxxxxxxxx
$43592
Jul 23, 2024
xxxxxxxxxxxxx
$25907
Jul 23, 2024
Elizabeth Rozek
Gc And Cco
xxxxxxxxxxxxx
$33724
Mar 28, 2024
David Happel
President & Ceo,director
xxxxxxxxxxxxx
$63646

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,013,414Insider9.82%16,844,984
3,011,575Insider9.82%16,834,704
3,007,272Insider9.80%16,810,650
3,000,275Insider9.78%16,771,537
3,000,275Insider9.78%16,771,537
2,031,118Insider6.62%11,353,950
1,381,898Institution4.50%7,724,810
1,036,689Institution3.38%5,795,092
1,010,091Institution3.29%5,646,409
639,200Insider2.08%3,573,128

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,036,689Institution3.38%5,795,092
302,930Institution0.99%1,693,379
185,000Institution0.60%1,034,150
147,171Institution0.48%822,686
104,790Institution0.34%585,776
54,280Institution0.18%303,425
45,000Institution0.15%251,550
30,000Institution0.10%167,700
17,922Institution0.06%100,184
16,638Institution0.05%93,006

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
763,985Institution2.49%2,116,238
246,106Institution0.80%681,714
61,488Institution0.20%343,718
11,043Institution0.04%60,737
867Institution<0.01%4,769

FAQ

Who Owns Sagimet Biosciences, Inc. Class A (SGMT)?
According to the latest TipRanks data, approximately 0.50% of the company's stock is held by institutional investors, 58.93% is held by insiders, and 30.42% is held by retail investors.
    What percentage of Sagimet Biosciences, Inc. Class A (SGMT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.50% of Sagimet Biosciences, Inc. Class A (SGMT) stock is held by institutional investors.
      What percentage of Sagimet Biosciences, Inc. Class A (SGMT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 30.42% of Sagimet Biosciences, Inc. Class A (SGMT) stock is held by retail investors.
        Who owns the most shares of Sagimet Biosciences, Inc. Class A (SGMT)?
        Patrick Kerins owns the most shares of Sagimet Biosciences, Inc. Class A (SGMT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis